Effect of dobutamine on skeletal muscle metabolism in patients with congestive heart failure.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  American Journal of Cardiology

• Publication date

  1990-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9149(90)90325-UPMID 2330898
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.

  1989cited by this paper
• Detection of abnormal calf muscle metabolism in patients with heart failure using phosphorus-31 nuclear magnetic resonance.

  1988cited by this paper
• Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow.

  1987cited by this paper
• Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow.

  1986cited by this paper
• Detection of skeletal muscle hypoperfusion during exercise using phosphorus-31 nuclear magnetic resonance spectroscopy.

  1986cited by this paper
• Phosphorus nuclear magnetic resonance spectroscopy in vivo.

  1985cited by this paper
• Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: role of cardiac pump dysfunction as determined by the effect of dobutamine.

  1984cited by this paper
• Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle.

  1984cited by this paper
• Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failure.

  1983cited by this paper
• Oxygen Utilization and Ventilation During Exercise in Patients with Chronic Cardiac Failure

  1982cited by this paper
• Mitochondrial regulation of phosphocreatine/inorganic phosphate ratios in exercising human muscle: a gated 31P NMR study.

  1981cited by this paper
• Noninvasive, nondestructive approaches to cell bioenergetics.

  1980cited by this paper
• Dobutamine: a new synthetic cardioactive sympathetic amine.

  1979cited by this paper
• Lactate release in relation to tissue lactate in human skeletal muscle during exercise.

  1978cited by this paper
• Comparative Hemodynamic Effects of Inotropic and Vasodilator Drugs in Severe Heart Failure

  1977cited by this paper
• Comparative systemic and regional hemodynamic effects of dopamine and dobutamine.

  1975cited by this paper
• Determination of intracellular pH by 31P magnetic resonance.

  1973cited by this paper

• Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors

  2024influential citation
• Exertional Cardiac and Pulmonary Vascular Hemodynamics Among Patients with Heart Failure with Reduced Ejection Fraction.

  2023cites this paper
• Skeletal Muscle Contractile Function in Heart Failure With Reduced Ejection Fraction—A Focus on Nitric Oxide

  2022cites this paper
• Is Exercise Training Appropriate for Patients With Advanced Heart Failure Receiving Continuous Inotropic Infusion? A Review

  2018cites this paper
• Mechanisms of exercise intolerance in chronic heart failureand type 2 diabetes mellitus

  2018cites this paper
• Cardioskeletal Myopathies in Congenital Heart Diseases

  2017cites this paper
• Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure.

  2017cites this paper
• Clinical management of chronic obstructive pulmonary disease patients with muscle dysfunction.

  2016cites this paper
• Dietary Nitrate and Skeletal Muscle Contractile Function in Heart Failure

  2016cites this paper
• Skeletal Muscle Changes in Chronic Cardiac Disease and Failure.

  2015cites this paper
• Inotropes.

  2014cites this paper
• Metabolic and structural impairment of skeletal muscle in heart failure

  2013cites this paper
• Fatigue in Cardiorespiratory Conditions

  2013cites this paper
• Intrinsic skeletal muscle alterations in chronic heart failure patients: a disease-specific myopathy or a result of deconditioning?

  2012cites this paper
• Near-infrared spectroscopy during stagnant ischemia estimates central venous oxygen saturation and mixed venous oxygen saturation discrepancy in patients with severe left heart failure and additional sepsis/septic shock

  2010cites this paper
• Inotropic agents improve the peripheral microcirculation of patients with end-stage chronic heart failure.

  2008cites this paper
• Physiology of the abnormal response of heart failure patients to exercise

  2004cites this paper
• Exercise Programmes for Patients with Chronic Heart Failure

  2004cites this paper
• Vascular rarefaction in peripheral skeletal muscle after experimental heart failure.

  2003cites this paper
• Heart Failure and Fatigue

  2003cites this paper
• Stellenwert von trainingsbedingten Rückwirkungen am arteriellen Gefäßsystem und der Skelettmuskulatur in der Therapie der Herzinsuffizienz NYHA II/III

  2001cites this paper
• [Value of training-induced effects on arterial vascular system and skeletal muscles in therapy of NYHA II/III heart failure].

  2001cites this paper
• Exercise limitation in health and disease.

  2000cites this paper
• Consensus recommendations for the management of chronic heart failure. On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure.

  1999cites this paper
• Effects of dobutamine on ischemic vasodilation of the forearm in patients with severe congestive heart failure.

  1999cites this paper
• Cardiac and peripheral responses to exercise in patients with chronic heart failure.

  1999cites this paper
• Abnormal transoesophageal Doppler coronary flow reserve in patients with dilated cardiomyopathy: relationship to exercise capacity.

  1998cites this paper
• Non-invasive measurement of cardiac output and ventricular ejection fractions in chronic cardiac failure: relationship to impaired exercise tolerance.

  1997cites this paper
• Origins of Symptoms in Heart Failure

  1997cites this paper
• Physical deconditioning may be a mechanism for the skeletal muscle energy phosphate metabolism abnormalities in chronic heart failure.

  1996cites this paper
• Alteration of peripheral vasodilatory reserve capacity after cardioversion of atrial fibrillation.

  1996cites this paper
• The "muscle hypothesis" of chronic heart failure.

  1996cites this paper
• Delayed improvement in skeletal muscle metabolism and exercise capacity in patients with mitral stenosis following immediate hemodynamic amelioration by percutaneous transvenous mitral commissurotomy.

  1996cites this paper
• Explaining fatigue in congestive heart failure.

  1996cites this paper
• Effects of ACE inhibition and beta-blockade on skeletal muscle fiber types in dogs with moderate heart failure.

  1996cites this paper
• Knee extension dynamometer: a new device for dynamic isokinetic magnetic resonance spectroscopy experiments

  1996cites this paper
• [31P magnetic resonance spectroscopy: a noninvasive method for studying skeletal muscle metabolism in patients with arteriosclerosis obliterans of the vessels of the lower extremities and for assessing the efficacy of vasoprostan therapy].

  1996cites this paper
• Exercise intolerance in patients with chronic heart failure.

  1995cites this paper
• Dynamic cardiomyoplasty: effect of discontinuing latissimus dorsi muscle stimulation on left ventricular systolic and diastolic performance and exercise capacity.

  1995cites this paper
• Prolonged kinetics of recovery of oxygen consumption after maximal graded exercise in patients with chronic heart failure. Analysis with gas exchange measurements and NMR spectroscopy.

  1995cites this paper
• Metabolic control of the circulation: implications for congestive heart failure.

  1995cites this paper
• Magnetic resonance spectroscopy studies of human muscle.

  1994cites this paper
• Contribution of specific skeletal muscle metabolic abnormalities to limitation of exercise capacity in patients with chronic heart failure: a phosphorus 31 nuclear magnetic resonance study.

  1994cites this paper
• [Metabolic, morpho-histologic and biochemical changes in skeletal muscles in chronic cardiac failure].

  1994cites this paper
• The Effect of Continuous Infusion of Dobutamine on the Maximal Forearm Skin Blood Flow and Plasma Neuropeptide Y Level in Patients with Congestive Heart Failure

  1993cites this paper
• Physical and psychosocial side effects of antepartum hospital bed rest.

  1993cites this paper
• Organ blood flow protection in hypertension and congestive heart failure.

  1993cites this paper
• Cardiac output in heart failure

  1993cites this paper
• Decreased Proportion of Type I Myofibers in Skeletal Muscle of Dogs With Chronic Heart Failure

  1993cites this paper
• Chapter 19 The study of bioenergetics in vivo using nuclear magnetic resonance

  1992cites this paper
• Metabolic imaging in cardiology with radioisotope techniques and magnetic resonance spectroscopy

  1992cites this paper
• [Spectroscopy of phosphorus in nuclear magnetic resonance. General review of clinical applications to the study of human skeletal muscle].

  1991cites this paper
• Spectroscopie du phosphore en résonance magnétique nucléaire: Revue générale des applications cliniques à l'étude du muscle squelettique chezl'homme

  1991cites this paper
• Effect of PGE1 on altered distribution of regional blood flows in hyperdynamic sepsis.

  1991cites this paper
• Regional blood flow supply and demand in heart failure.

  1990cites this paper